Ann Marie Navar, MD, PhD

Assistant Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail 2400 Pratt St., Box 3850, Durham, NC 27705
Phone (919) 684-8111
In Their Words

Education and Training

  • Cardiovascular Disease Fellowship, Duke University School of Medicine, 2013 - 2016
  • Internal Medicine and Pediatrics Residency, Duke University School of Medicine, 2009 - 2013
  • Ph.D., Johns Hopkins University, 2009
  • M.D., Duke University School of Medicine, 2009
  • M.H.S., Johns Hopkins University, 2005

Publications

Nanna, Michael G., Ann Marie Navar, Daniel Wojdyla, and Eric D. Peterson. “The Association Between Low-Density Lipoprotein Cholesterol and Incident Atherosclerotic Cardiovascular Disease in Older Adults: Results From the National Institutes of Health Pooled Cohorts..” J Am Geriatr Soc 67, no. 12 (December 2019): 2560–67. https://doi.org/10.1111/jgs.16123.

PMID
31411740
Full Text

Sumarsono, Andrew, Muthiah Vaduganathan, Ezimamaka Ajufo, Ann Marie Navar, Gregg C. Fonarow, Sandeep R. Das, and Ambarish Pandey. “Contemporary Patterns of Medicare and Medicaid Utilization and Associated Spending on Sacubitril/Valsartan and Ivabradine in Heart Failure..” Jama Cardiol, November 18, 2019. https://doi.org/10.1001/jamacardio.2019.4982.

PMID
31738371
Full Text

Nanna, Michael G., Eric D. Peterson, Daniel Wojdyla, and Ann Marie Navar. “The Accuracy of Cardiovascular Pooled Cohort Risk Estimates in U.S. Older Adults..” J Gen Intern Med, October 30, 2019. https://doi.org/10.1007/s11606-019-05361-4.

PMID
31667745
Full Text

Sniderman, Allan D., George Thanassoulis, Tamara Glavinovic, Ann Marie Navar, Michael Pencina, Alberico Catapano, and Brian A. Ference. “Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review..” Jama Cardiol, October 23, 2019. https://doi.org/10.1001/jamacardio.2019.3780.

PMID
31642874
Full Text

Xian, Ying, Ann Marie Navar, Shuang Li, Zhuokai Li, Jennifer Robinson, Salim S. Virani, Michael J. Louie, et al. “Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry..” J Am Heart Assoc 8, no. 19 (October 2019). https://doi.org/10.1161/JAHA.119.013229.

PMID
31554462
Full Text

Elias, Pierre, Eric Peterson, Bob Wachter, Cary Ward, Eric Poon, and Ann Marie Navar. “Evaluating the Impact of Interruptive Alerts within a Health System: Use, Response Time, and Cumulative Time Burden..” Appl Clin Inform 10, no. 5 (October 2019): 909–17. https://doi.org/10.1055/s-0039-1700869.

PMID
31777057
Full Text

Bradley, Corey K., Peter Shrader, Robert J. Sanchez, Eric D. Peterson, and Ann Marie Navar. “The patient journey with proprotein convertase subtilisin/kexin type 9 inhibitors in community practice..” J Clin Lipidol 13, no. 5 (September 2019): 725–34. https://doi.org/10.1016/j.jacl.2019.06.008.

PMID
31371271
Full Text

Nanna, Michael G., Ann Marie Navar, Tracy Y. Wang, Shuang Li, Salim S. Virani, Zhuokai Li, Jennifer G. Robinson, et al. “Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: Results from the Patient and Provider Assessment of Lipid Management (PALM) registry..” Am Heart J 214 (August 2019): 113–24. https://doi.org/10.1016/j.ahj.2019.05.009.

PMID
31202098
Full Text

Pages